NCT01838395 2024-09-19Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML PatientsBioLineRx, Ltd.Phase 2 Completed42 enrolled 19 charts
NCT02639559 2023-11-07Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological MalignanciesWashington University School of MedicinePhase 2 Completed50 enrolled 23 charts